Clinical Studies

VACCELERATE Clinical Studies

Clinical trials serve the purpose of clarifying open questions regarding new vaccines, therapies or medicines. By participating in clinical trials, you can make a major contribution to scientific progress. As a study participant you support the research of diseases and the development of new treatment options and at the same time receive comprehensive medical care.

VACCELERATE is carrying out three COVID-19 vaccine trials. The results will be linked here as soon as they are published. 

STUDY 1: EU-COVAT-1 AGED

STUDY 2: EU-COVAT-2 BOOSTAVAC

An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a booster mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2

Lead: Patrick Mallon, Institution/Sponsor: NUID UCD, Ireland

Details:

https://twitter.com/vaccelerate_eu/status/1503688207506063360

https://www.ucd.ie/research/news/2022/vacceleratesecondphaseiitrialboostavacstartsinireland/body,615411,en.html

https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-004889-35/IE

STUDY 3: EU-COVPT-1 COVACC

A Phase 2, Comparative Randomised Trial to Evaluate the Impact of Reduced COVID‐19 mRNA Vaccination Regimen on Immunological Responses and Reactogenicity in Paediatric Subjects with Prior SARS‐CoV‐2 Immunity

Lead: Patricia Bruijning-Verhagen, Institution/Sponsor: UMCU, Netherlands

COVID-19 Point Prevalence Germany

CECAD Newsletter 01/2022

CECAD Excellent in Aging Research
Cluster of Excellence at the University of Cologne

https://www.cecad.uni-koeln.de/home

Learn more about the involvement of LAB-Net, the Central Laboratory at the University of Antwerp, in AGED and BOOSTAVAC: https://www.combacte.com/news/lab-net-highly-involved-aged-boostavac/